Quantification of [11C]FLB 457 Binding to Extrastriatal Dopamine Receptors in the Human Brain

Positron emission tomography (PET) has hitherto been used to examine D2 dopamine receptor binding in the striatum, a region with a high density of receptors. Research has been hampered by the lack of suitable radioligands for detection of the low-density D2 dopamine receptor populations in the limbi...

Full description

Saved in:
Bibliographic Details
Published inJournal of cerebral blood flow and metabolism Vol. 19; no. 10; pp. 1164 - 1173
Main Authors Olsson, Hans, Halldin, Christer, Swahn, Carl-Gunnar, Farde, Lars
Format Journal Article
LanguageEnglish
Published London, England SAGE Publications 01.10.1999
Lippincott Williams & Wilkins
Subjects
Online AccessGet full text
ISSN0271-678X
1559-7016
DOI10.1097/00004647-199910000-00013

Cover

Abstract Positron emission tomography (PET) has hitherto been used to examine D2 dopamine receptor binding in the striatum, a region with a high density of receptors. Research has been hampered by the lack of suitable radioligands for detection of the low-density D2 dopamine receptor populations in the limbic and cortical dopamine systems that are implicated in the patophysiology of schizophrenia. [11C]FLB 457 is a new radioligand with the very high affinity of 20 pmol/L (Ki) for the D2 and D3 dopamine receptor subtypes. This study in eight healthy subjects was designed to evaluate the suitability of [11C]FLB 457 for quantification of extrastriatal D2/D3 dopamine receptors. PET-data were acquired in the three-dimensional mode and the arterial input function was corrected for labeled metabolites. The standard three-compartment model and four derived approaches were applied to calculate and compare the binding potentials. Besides the striatum, conspicuous radioactivity was found in extrastriatal regions such as the thalamus, the anterior cinguli, and the temporal and frontal cortices. The time activity curves could be described by the three compartment model. The different approaches gave similar binding potential values and the rank order between regions was consistent with that found in vitro. The short time of a PET measurement using [11C]FLB 457 (63 minutes) seemed not to be sufficient for reliable determination of the high binding potential in the striatum. These results are of principal importance because they show the potential for PET quantification of minute receptor populations in the human brain.
AbstractList Positron emission tomography (PET) has hitherto been used to examine D2 dopamine receptor binding in the striatum, a region with a high density of receptors. Research has been hampered by the lack of suitable radioligands for detection of the low-density D2 dopamine receptor populations in the limbic and cortical dopamine systems that are implicated in the pathophysiology of schizophrenia. [11C]FLB 457 is a new radioligand with the very high affinity of 20 pmol/L (K(i)) for the D2 and D3 dopamine receptor subtypes. This study in eight healthy subjects was designed to evaluate the suitability of [11C]FLB 457 for quantification of extrastriatal D2/D3 dopamine receptors. PET-data were acquired in the three-dimensional mode and the arterial input function was corrected for labeled metabolites. The standard three-compartment model and four derived approaches were applied to calculate and compare the binding potentials. Besides the striatum, conspicuous radioactivity was found in extrastriatal regions such as the thalamus, the anterior cinguli, and the temporal and frontal cortices. The time activity curves could be described by the three compartment model. The different approaches gave similar binding potential values and the rank order between regions was consistent with that found in vitro. The short time of a PET measurement using [11C]FLB 457 (63 minutes) seemed not to be sufficient for reliable determination of the high binding potential in the striatum. These results are of principal importance because they show the potential for PET quantification of minute receptor populations in the human brain.
Positron emission tomography (PET) has hitherto been used to examine D2 dopamine receptor binding in the striatum, a region with a high density of receptors. Research has been hampered by the lack of suitable radioligands for detection of the low-density D2 dopamine receptor populations in the limbic and cortical dopamine systems that are implicated in the patophysiology of schizophrenia. [ 11 C]FLB 457 is a new radioligand with the very high affinity of 20 pmol/L (K i ) for the D2 and D3 dopamine receptor subtypes. This study in eight healthy subjects was designed to evaluate the suitability of [ 11 C]FLB 457 for quantification of extrastriatal D2/D3 dopamine receptors. PET-data were acquired in the three-dimensional mode and the arterial input function was corrected for labeled metabolites. The standard three-compartment model and four derived approaches were applied to calculate and compare the binding potentials. Besides the striatum, conspicuous radioactivity was found in extrastriatal regions such as the thalamus, the anterior cinguli, and the temporal and frontal cortices. The time activity curves could be described by the three compartment model. The different approaches gave similar binding potential values and the rank order between regions was consistent with that found in vitro. The short time of a PET measurement using [ 11 C]FLB 457 (63 minutes) seemed not to be sufficient for reliable determination of the high binding potential in the striatum. These results are of principal importance because they show the potential for PET quantification of minute receptor populations in the human brain.
Positron emission tomography (PET) has hitherto been used to examine D2 dopamine receptor binding in the striatum, a region with a high density of receptors. Research has been hampered by the lack of suitable radioligands for detection of the low-density D2 dopamine receptor populations in the limbic and cortical dopamine systems that are implicated in the patophysiology of schizophrenia. [11C]FLB 457 is a new radioligand with the very high affinity of 20 pmol/L (Ki) for the D2 and D3 dopamine receptor subtypes. This study in eight healthy subjects was designed to evaluate the suitability of [11C]FLB 457 for quantification of extrastriatal D2/D3 dopamine receptors. PET-data were acquired in the three-dimensional mode and the arterial input function was corrected for labeled metabolites. The standard three-compartment model and four derived approaches were applied to calculate and compare the binding potentials. Besides the striatum, conspicuous radioactivity was found in extrastriatal regions such as the thalamus, the anterior cinguli, and the temporal and frontal cortices. The time activity curves could be described by the three compartment model. The different approaches gave similar binding potential values and the rank order between regions was consistent with that found in vitro. The short time of a PET measurement using [11C]FLB 457 (63 minutes) seemed not to be sufficient for reliable determination of the high binding potential in the striatum. These results are of principal importance because they show the potential for PET quantification of minute receptor populations in the human brain.
Author Swahn, Carl-Gunnar
Halldin, Christer
Olsson, Hans
Farde, Lars
Author_xml – sequence: 1
  givenname: Hans
  surname: Olsson
  fullname: Olsson, Hans
  organization: Karolinska Institutet, Department of Clinical Neuroscience, Psychiatry Section, Stockholm, Sweden
– sequence: 2
  givenname: Christer
  surname: Halldin
  fullname: Halldin, Christer
  organization: Karolinska Institutet, Department of Clinical Neuroscience, Psychiatry Section, Stockholm, Sweden
– sequence: 3
  givenname: Carl-Gunnar
  surname: Swahn
  fullname: Swahn, Carl-Gunnar
  organization: Karolinska Institutet, Department of Clinical Neuroscience, Psychiatry Section, Stockholm, Sweden
– sequence: 4
  givenname: Lars
  surname: Farde
  fullname: Farde, Lars
  organization: Karolinska Institutet, Department of Clinical Neuroscience, Psychiatry Section, Stockholm, Sweden
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1962093$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/10532641$$D View this record in MEDLINE/PubMed
http://kipublications.ki.se/Default.aspx?queryparsed=id:1927724$$DView record from Swedish Publication Index
BookMark eNqFkV1LBCEUhiWK2j7-QnjR7ZTO6DjeBO22fcBCFF0EEXLGccra1UVdqn-ftVtBNwniUZ_zou-7jdaddwYhTMkhJVIckTxYzURBpZT0c1fkSas1NKCcy0IQWq-jASkFLWrR3G2h7RifM9JUnG-iLUp4VdaMDtDD9QJcsr3VkKx32Pf4ntLRw9lkiBkXeGhdZ90jTh6P31KAmIKFBFN86ucws87gG6PNPPkQsXU4PRl8sZiBw8MA1u2ijR6m0eyt1h10eza-HV0Uk6vzy9HJpNCMy1RwMD3lhLWt7JgAKTkroSyFlK3ojKDQazAMakmasjMt6aoO2rZrel3ShuhqBxVL2fhq5otWzYOdQXhXHqxaHb3kyqiaVE0tMr-_5PPNzHQ__LctGThYARA1TPsATtv4y8m6JLLK2PES08HHGEyvtE1fPman7DTrqc-41Hdc6icu9RVXFmj-CPw-5d9WvvozPBr17BfBZYf_7_sAJ5WmoQ
CODEN JCBMDN
CitedBy_id crossref_primary_10_1016_j_neuroimage_2009_12_006
crossref_primary_10_1176_appi_ajp_158_2_308
crossref_primary_10_1016_j_schres_2010_03_043
crossref_primary_10_1016_j_neuroimage_2008_05_056
crossref_primary_10_1017_S1461145707008358
crossref_primary_10_1111_adb_12812
crossref_primary_10_1016_j_biopsych_2004_11_009
crossref_primary_10_1097_00006231_200503000_00011
crossref_primary_10_1371_journal_pone_0023298
crossref_primary_10_1523_JNEUROSCI_3446_08_2008
crossref_primary_10_1046_j_1471_4159_2002_00895_x
crossref_primary_10_1016_j_bmc_2005_06_055
crossref_primary_10_1016_j_schres_2018_10_008
crossref_primary_10_1002_syn_20765
crossref_primary_10_1016_j_neulet_2018_03_006
crossref_primary_10_1109_23_940161
crossref_primary_10_1093_schbul_sby076
crossref_primary_10_1016_j_pscychresns_2011_01_011
crossref_primary_10_1016_S1053_8119_03_00166_6
crossref_primary_10_1371_journal_pone_0006725
crossref_primary_10_1007_s12149_007_0083_2
crossref_primary_10_1007_s00213_005_0092_6
crossref_primary_10_1523_JNEUROSCI_2097_04_2005
crossref_primary_10_1002_syn_20806
crossref_primary_10_1016_j_nucmedbio_2010_04_138
crossref_primary_10_1002_syn_20926
crossref_primary_10_1016_S0304_3940_01_01552_X
crossref_primary_10_1176_ajp_2007_164_4_630
crossref_primary_10_1002_1099_1344_20001015_43_11_1069__AID_JLCR390_3_0_CO_2_N
crossref_primary_10_1212_WNL_54_7_1482
crossref_primary_10_3390_ijms23042005
crossref_primary_10_1016_j_neuroimage_2012_11_045
crossref_primary_10_1073_pnas_0911805107
crossref_primary_10_1111_j_1460_9568_2004_03622_x
crossref_primary_10_1038_jcbfm_2014_237
crossref_primary_10_1002_syn_20813
crossref_primary_10_1021_cr0782426
crossref_primary_10_1371_journal_pone_0017723
crossref_primary_10_1007_s12264_024_01188_0
crossref_primary_10_1016_j_neuroimage_2004_02_002
crossref_primary_10_1038_tp_2012_40
crossref_primary_10_1093_brain_awt337
crossref_primary_10_1006_phrs_2000_0782
crossref_primary_10_1016_j_nucmedbio_2007_09_009
crossref_primary_10_1097_00004647_200112000_00014
crossref_primary_10_1177_0271678X19874770
crossref_primary_10_2310_7290_2013_00065
crossref_primary_10_1006_nimg_2000_0717
crossref_primary_10_1097_MNM_0b013e328356fbc3
crossref_primary_10_1002_syn_20062
crossref_primary_10_1111_j_1755_5949_2010_00222_x
crossref_primary_10_1007_s12149_019_01405_1
crossref_primary_10_1016_j_icrp_2008_08_005
crossref_primary_10_1016_j_icrp_2008_08_007
crossref_primary_10_1097_00006231_200111000_00008
crossref_primary_10_1523_JNEUROSCI_3933_10_2010
crossref_primary_10_1002_syn_20628
crossref_primary_10_1006_nimg_2001_0879
crossref_primary_10_1016_S0969_8051_00_00154_2
crossref_primary_10_1016_j_pscychresns_2009_04_006
crossref_primary_10_1002_syn_21566
crossref_primary_10_1006_nimg_2001_0761
crossref_primary_10_1007_s12194_015_0343_0
crossref_primary_10_1080_09540261_2017_1398139
crossref_primary_10_1017_S1461145708009577
crossref_primary_10_1371_journal_pone_0049483
crossref_primary_10_3390_ijms22041719
crossref_primary_10_1016_S0006_3223_02_01602_5
crossref_primary_10_1038_sj_npp_1301242
crossref_primary_10_1016_j_apradiso_2008_05_010
crossref_primary_10_1016_j_neuroimage_2009_07_021
crossref_primary_10_1155_2013_627496
crossref_primary_10_1002_jnr_24779
crossref_primary_10_1007_s12149_010_0407_5
crossref_primary_10_1097_00004714_200302000_00002
crossref_primary_10_1016_j_pain_2004_01_013
crossref_primary_10_1038_s41380_020_00934_w
crossref_primary_10_1016_j_neuroimage_2009_02_031
crossref_primary_10_1016_j_jad_2006_11_010
crossref_primary_10_1007_s00259_008_0969_9
crossref_primary_10_1038_sj_jcbfm_9600339
crossref_primary_10_1016_j_euroneuro_2019_06_004
crossref_primary_10_1038_sj_npp_1301108
crossref_primary_10_1016_j_biopsych_2022_05_009
crossref_primary_10_1038_jcbfm_2009_270
crossref_primary_10_1038_sj_jcbfm_9600340
crossref_primary_10_1021_acsmedchemlett_8b00504
crossref_primary_10_1523_JNEUROSCI_5689_09_2010
crossref_primary_10_1038_jcbfm_2014_150
crossref_primary_10_2967_jnumed_108_058503
crossref_primary_10_1038_jcbfm_2013_55
crossref_primary_10_2310_7290_2015_00006
crossref_primary_10_1007_s00213_004_1830_x
crossref_primary_10_1016_j_neuroimage_2006_02_053
crossref_primary_10_1016_j_neuroimage_2020_117523
crossref_primary_10_1002_1098_2396_200011_38_2_138__AID_SYN4_3_0_CO_2_7
crossref_primary_10_1053_j_semnuclmed_2015_09_003
crossref_primary_10_1016_j_neuroimage_2010_02_006
crossref_primary_10_1124_jpet_106_109173
crossref_primary_10_1007_s00259_005_0027_9
crossref_primary_10_1016_j_nbd_2012_06_021
crossref_primary_10_1017_S1461145707008103
crossref_primary_10_1016_j_drugalcdep_2016_01_029
crossref_primary_10_1038_npp_2009_88
crossref_primary_10_1016_j_neuroimage_2006_11_008
crossref_primary_10_1016_j_pnpbp_2005_06_011
crossref_primary_10_1176_appi_ajp_158_6_926
crossref_primary_10_1371_journal_pone_0010670
crossref_primary_10_1016_S0304_3959_02_00121_5
crossref_primary_10_1093_brain_awy133
crossref_primary_10_1371_journal_pone_0076905
crossref_primary_10_1038_sj_npp_1300916
crossref_primary_10_2967_jnumed_111_094029
crossref_primary_10_1523_JNEUROSCI_1037_23_2023
crossref_primary_10_1007_s11682_017_9779_7
Cites_doi 10.1007/s002130050131
10.1111/j.2042-7158.1973.tb10025.x
10.1002/(SICI)1098-2396(199606)23:2<115::AID-SYN7>3.0.CO;2-C
10.1097/00004647-199601000-00005
10.1097/00002826-199201001-00296
10.1002/syn.890190103
10.1002/syn.890200303
10.1007/978-94-011-0429-6_5
10.1002/ana.410150302
10.1073/pnas.91.23.11271
10.1002/ana.410060502
10.1016/0969-8051(96)00078-9
10.1016/0006-8993(93)90878-Q
10.1038/jcbfm.1986.27
10.1126/science.6604315
10.1007/BF02244067
10.1016/0306-4522(95)00357-6
10.1038/jcbfm.1989.98
10.1109/TAC.1974.1100705
10.1073/pnas.86.16.6412
10.1016/0169-328X(93)90188-U
10.1097/00004728-198102000-00027
10.1016/S0006-8993(97)01078-0
10.1007/s002130050420
10.1038/jcbfm.1990.127
10.1016/S0166-2236(84)80013-2
10.1214/aos/1176344136
10.1016/S0893-133X(98)00066-9
10.1073/pnas.82.11.3863
10.1109/23.12815
10.1006/nimg.1996.0066
10.1097/00004728-199401000-00023
10.1038/385590a0
10.1176/ajp.148.11.1474
10.1038/385634a0
10.1038/sj.npp.1380111
10.1038/347146a0
10.1016/0006-8993(91)91456-B
10.1016/0014-2999(76)90311-3
10.1038/386830a0
ContentType Journal Article
Copyright 1999 The International Society for Cerebral Blood Flow and Metabolism
1999 INIST-CNRS
Copyright_xml – notice: 1999 The International Society for Cerebral Blood Flow and Metabolism
– notice: 1999 INIST-CNRS
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
ADTPV
AOWAS
DOI 10.1097/00004647-199910000-00013
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
SwePub
SwePub Articles
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
CrossRef

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Chemistry
EISSN 1559-7016
EndPage 1173
ExternalDocumentID oai_swepub_ki_se_603867
10532641
1962093
10_1097_00004647_199910000_00013
10.1097_00004647-199910000-00013
Genre Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S
Journal Article
GrantInformation_xml – fundername: PHS HHS
  grantid: R0-41205
GroupedDBID ---
-Q-
-TM
.55
.GJ
0R~
29K
2WC
36B
39C
3O-
4.4
53G
54M
5GY
5RE
5VS
70F
7X7
88E
8AO
8FE
8FH
8FI
8FJ
8R4
8R5
AABMB
AACKU
AACMV
AADUE
AAEWN
AAGGD
AAGMC
AAJIQ
AAJPV
AAKGS
AANSI
AAPEO
AAQGT
AAQXH
AAQXI
AARDL
AARIX
AATAA
AATBZ
AAUAS
AAVDI
AAXOT
AAYTG
AAZBJ
ABAWP
ABAWZ
ABCCA
ABCJG
ABDWY
ABEIX
ABFWQ
ABHKI
ABJNI
ABJZC
ABKRH
ABLUO
ABNCE
ABPGX
ABPNF
ABQKF
ABQNX
ABQXT
ABRHV
ABUJY
ABUWG
ABVFX
ABXGC
ABYTW
ACARO
ACDSZ
ACDXX
ACFEJ
ACFMA
ACGBL
ACGFO
ACGFS
ACGZU
ACJER
ACJTF
ACLFY
ACLHI
ACNXM
ACOFE
ACOXC
ACPRK
ACROE
ACSIQ
ACUAV
ACUIR
ACXKE
ACXMB
ADBBV
ADEBD
ADEIA
ADMPF
ADNON
ADRRZ
ADTBJ
ADUKL
ADVBO
ADZZY
AECGH
AENEX
AEPTA
AEQLS
AESZF
AEUHG
AEWDL
AEWHI
AEXFG
AEXNY
AFEET
AFFNX
AFFZS
AFKRA
AFKRG
AFMOU
AFOSN
AFQAA
AFUIA
AFVCE
AGHKR
AGKLV
AGNHF
AGPXR
AGWFA
AHDMH
AHMBA
AIGRN
AJABX
AJEFB
AJMMQ
AJSCY
AJUZI
AJXAJ
AJXGE
ALIPV
ALKWR
ALMA_UNASSIGNED_HOLDINGS
AMCVQ
ANDLU
AOIJS
ARTOV
AUTPY
AYAKG
B8M
BAWUL
BBNVY
BBRGL
BDDNI
BENPR
BHPHI
BKIIM
BKSCU
BPACV
BPHCQ
BSEHC
BVXVI
BWJAD
C45
CAG
CBRKF
CCPQU
CDWPY
CFDXU
COF
CORYS
CQQTX
CS3
CUTAK
D-I
DC-
DC.
DIK
DOPDO
DV7
E3Z
EBS
EE.
EJD
EMOBN
F5P
FHBDP
FYUFA
GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION
GX1
H13
HCIFZ
HMCUK
HYE
HZ~
J8X
JSO
K.F
KQ8
LK8
M1P
M7P
O9-
OK1
OVD
P2P
P6G
PHGZM
PHGZT
PQQKQ
PROAC
PSQYO
Q1R
Q2X
RNS
RNTTT
ROL
RPM
SASJQ
SAUOL
SCNPE
SFC
SHG
SPQ
SPV
TEORI
TR2
UKHRP
W2D
X7M
YFH
YOC
ZGI
ZONMY
ZPPRI
ZRKOI
ZSSAH
ZXP
AAYXX
AJGYC
CITATION
AAEJI
AAPII
AJVBE
IQODW
PJZUB
PPXIY
PQGLB
3V.
88A
AAMGE
ACTQU
AEUIJ
AIOMO
ALTZF
CGR
CUY
CVF
ECM
EIF
M0L
M4V
NPM
ADTPV
AJHME
AOWAS
PUEGO
ID FETCH-LOGICAL-c459t-5aef1504bb9d47a99542a22799b7de71afcae4a69082deb0d3dabbd8fc2180c3
ISSN 0271-678X
IngestDate Mon Sep 01 03:35:20 EDT 2025
Wed Feb 19 01:35:21 EST 2025
Mon Jul 21 09:14:13 EDT 2025
Tue Jul 01 05:24:55 EDT 2025
Thu Apr 24 23:05:27 EDT 2025
Tue Jun 17 22:35:07 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 10
Keywords Human
[11C]FLB 457
Positron emission tomography
D2 dopamine receptors
Compartment analysis
Extrastriatal
Radionuclide study
Compartmental model
D2 Dopamine receptor
Central nervous system
Exploration
Brain (vertebrata)
Positron
Emission tomography
Language English
License https://journals.sagepub.com/page/policies/text-and-data-mining-license
CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c459t-5aef1504bb9d47a99542a22799b7de71afcae4a69082deb0d3dabbd8fc2180c3
PMID 10532641
PageCount 10
ParticipantIDs swepub_primary_oai_swepub_ki_se_603867
pubmed_primary_10532641
pascalfrancis_primary_1962093
crossref_citationtrail_10_1097_00004647_199910000_00013
crossref_primary_10_1097_00004647_199910000_00013
sage_journals_10_1097_00004647_199910000_00013
ProviderPackageCode CITATION
AAYXX
PublicationCentury 1900
PublicationDate 1999-10-01
PublicationDateYYYYMMDD 1999-10-01
PublicationDate_xml – month: 10
  year: 1999
  text: 1999-10-01
  day: 01
PublicationDecade 1990
PublicationPlace London, England
PublicationPlace_xml – name: London, England
– name: Hagerstown, MD
– name: United States
PublicationTitle Journal of cerebral blood flow and metabolism
PublicationTitleAlternate J Cereb Blood Flow Metab
PublicationYear 1999
Publisher SAGE Publications
Lippincott Williams & Wilkins
Publisher_xml – name: SAGE Publications
– name: Lippincott Williams & Wilkins
References Gurevich, Joyce 1999; 20
Yosef, Volkow, Schlyer, Fowler, Wolf, Wang, Smith, Brodie, Warner 1995; 19
Mintun, Raichle, Kilbourn, Wooten, Welch 1984; 15
Halldin, Farde, Hogberg, Mohell, Hall, Suhara, Karlsson, Nakashima, Swahn 1995a; 36
Kuikka, Åkerman, Hiltunen, Bergström, Räsänen, Vanninen, Halldin, Tiihonen 1997; 24
Logan, Fowler, Volkow, Wolf, Dewey, Schlyer, MacGregor, Hitzemann, Bendriem, Gatley, Christman 1990; 10
Wienhard, Dahlbom, Eriksson, Michel, Bruckbauer, Pietrzyk, Heiss 1994; 18
Fibiger 1994; 55
Bouthenet, Souil, Martres, Sokoloff, Giros, Schwartz 1991; 564
Davis, Kahn, Ko, Davidson 1991; 148
Farde, Suhara, Nyberg, Karlsson, Nakashima, Hietala, Halldin 1997b; 133
Okubo, Suhara, Suzuki, Kobayashi, Inoue, Terasaki, Someya, Sassa, Sudo, Matsushima, Iyo, Tateno, Toru 1997; 385
Sokoloff, Giros, Martres, Bouthenet, Schwartz 1990; 357
Loc'h, Halldin, Bottlaender, Swahn, Moresco, Mazière, Farde, Mazière 1996; 23
Volkow, Wang, Fowler, Logan, Gatley, Hitzemann, Chen, Dewey, Pappas 1997; 386
Lammertsma, Hume 1996; 4
Andén, Stock 1973; 25
Eriksson, Holte, Bohm, Kesselberg, Hovander 1988; 35
Landwehrmeyer, Mengod, Palacios 1993; 18
Lammertsma, Bench, Hume, Osman, Gunn, Brooks, Frackowiak 1996; 16
Farde, Eriksson, Blomquist, Halldin 1989; 9
Murray, Ryoo, Gurevich, Joyce 1994; 91
Phelps, Huang, Hoffman, Selin, Sokoloff, Kuhl 1979; 6
Wagner, Burns, Dannals, Wong, Lågström, Duelfer, Frost, Ravert, Links, Rosenbloom, Lukas, Kramer, Kuhar 1983; 221
Farde, Ehrin, Eriksson, Greitz, Hall, Hedstrom, Litton, Sedvall 1985; 82
Kessler, Whetsell, Ansari, Votaw, De Paulis, Clanton, Schmidt, Mason, Manning 1993; 609
Farde, Gustavsson, Jönsson 1997a; 385
Hall, Farde, Halldin, Hurd, Pauli, Sedvall 1996a; 23
Wong, Gjedde, Wagner 1986; 6
Deutch, Duman 1996; 70
Lidow, Goldman-Rakic, Rakic, Innis 1989; 86
Costall, Naylor 1976; 35
Weinberger, Berman, Daniel 1992; 15
Schwartz 1978; 6
Swahn, Halldin, Lundkvist, Olsson, Karlsson, Farde 1997; 40
Hall, Högberg, Halldin, Köhler, Ström, Ross, Larsson, Farde 1991; 103
Suzuki, Hurd, Sokoloff, Schwartz, Sedvall 1998; 779
Farde, Hall, Pauli, Halldin 1995; 20
Bergström, Boëthius, Eriksson, Greitz, Ribbe, Widén 1981; 5
Nakashima, Farde 1995; 15
Hall, Sedvall, Magnusson, Kopp, Halldin, Farde 1994; 11
Hall, Halldin, Dijkstra, Wikström, Wise, Pugsley, Sokoloff, Pauli, Farde, Sedvall 1996b; 128
Akaike 1974; 19
Janowsky, Neve, Kinzie, Taylor, de Paulis, Belknap 1992; 261
Stevens 1991; 55
bibr3-00004647-199910000-00013
bibr13-00004647-199910000-00013
bibr39-00004647-199910000-00013
bibr42-00004647-199910000-00013
bibr30-00004647-199910000-00013
bibr27-00004647-199910000-00013
bibr44-00004647-199910000-00013
bibr32-00004647-199910000-00013
bibr5-00004647-199910000-00013
Kuikka J (bibr25-00004647-199910000-00013) 1997; 24
bibr18-00004647-199910000-00013
bibr19-00004647-199910000-00013
bibr17-00004647-199910000-00013
Fibiger HC (bibr15-00004647-199910000-00013) 1994; 55
Nakashima Y (bibr35-00004647-199910000-00013) 1995; 15
bibr1-00004647-199910000-00013
bibr40-00004647-199910000-00013
bibr12-00004647-199910000-00013
bibr2-00004647-199910000-00013
bibr4-00004647-199910000-00013
Janowsky A (bibr23-00004647-199910000-00013) 1992; 261
bibr14-00004647-199910000-00013
bibr26-00004647-199910000-00013
bibr38-00004647-199910000-00013
bibr16-00004647-199910000-00013
Swahn C (bibr43-00004647-199910000-00013) 1997; 40
bibr31-00004647-199910000-00013
bibr6-00004647-199910000-00013
Leenders K (bibr29-00004647-199910000-00013) 1997
bibr28-00004647-199910000-00013
bibr20-00004647-199910000-00013
bibr8-00004647-199910000-00013
bibr45-00004647-199910000-00013
bibr33-00004647-199910000-00013
bibr47-00004647-199910000-00013
bibr22-00004647-199910000-00013
bibr46-00004647-199910000-00013
bibr7-00004647-199910000-00013
bibr34-00004647-199910000-00013
bibr10-00004647-199910000-00013
Stevens JR (bibr41-00004647-199910000-00013) 1991; 55
bibr48-00004647-199910000-00013
bibr49-00004647-199910000-00013
Halldin C (bibr21-00004647-199910000-00013) 1995; 36
bibr37-00004647-199910000-00013
bibr24-00004647-199910000-00013
bibr11-00004647-199910000-00013
bibr9-00004647-199910000-00013
bibr36-00004647-199910000-00013
References_xml – volume: 24
  start-page: 483
  year: 1997
  end-page: 487
  article-title: Striatal and extrastriatal imaging of dopamine D2 receptors in the living human brain with [123I]epidepride single-photon emission tomography
  publication-title: Eur J Nucl Med
– volume: 148
  start-page: 1474
  year: 1991
  end-page: 1486
  article-title: Dopamine in schizophrenia: a review and reconceptualization
  publication-title: Am J Psychiatry
– volume: 70
  start-page: 377
  year: 1996
  end-page: 389
  article-title: The effects of antipsychotic drugs on Fos protein expression in the prefrontal cortex: cellular localization and pharmacological characterization
  publication-title: Neuroscience
– volume: 25
  start-page: 346
  year: 1973
  article-title: Effect of clozapine on the turnover of dopamine in the corpus striatum and the limbic system
  publication-title: J Pharmacol
– volume: 6
  start-page: 371
  year: 1979
  end-page: 388
  article-title: Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method
  publication-title: Ann Neurol
– volume: 40
  start-page: 179
  year: 1997
  end-page: 181
  article-title: Labelling of lipophilic metabolite of [11C]raclopride and investigation of it's brain uptake in a Cynomolgus Monkey with PET
  publication-title: J Labelled Cpd Radiopharm
– volume: 609
  start-page: 237
  year: 1993
  end-page: 243
  article-title: Identification of extrastriatal dopamine D receptors in post mortem human brain with [ I]epidepride
  publication-title: Brain Res
– volume: 357
  start-page: 146
  year: 1990
  end-page: 151
  article-title: Molecular cloning and characterization of a novel dopamine receptor (D ) as a target for neuroleptics
  publication-title: Nature
– volume: 35
  start-page: 703
  year: 1988
  end-page: 707
  article-title: Automated blood sampling systems for positron emission tomography
  publication-title: IEEE Trans Nucl Sci
– volume: 5
  start-page: 136
  year: 1981
  end-page: 141
  article-title: Head fixation device for reproducible position alignment in transmission CT and positron emission tomography
  publication-title: J Comp Assist Tomogr
– volume: 6
  start-page: 461
  year: 1978
  end-page: 564
  article-title: Estimating the dimension of a model
  publication-title: Ann Statist
– volume: 103
  start-page: 6
  year: 1991
  end-page: 18
  article-title: NCQ 298, a new selective iodinated salicylamide ligand for the labelling of dopamine-D receptors
  publication-title: Psychopharmacol
– volume: 261
  start-page: 1282
  year: 1992
  end-page: 1290
  article-title: Extrastriatal dopamine D receptors: distribution, pharmacological characterization and region-specific regulation by clozapine
  publication-title: J Pharmacol Exp Therapeutics
– volume: 18
  start-page: 110
  year: 1994
  end-page: 118
  article-title: The ECAT EXACT HR: performance of a new high resolution positron scanner
  publication-title: J Comput Assist Tomogr
– volume: 6
  start-page: 137
  year: 1986
  end-page: 146
  article-title: Quantification of neuroreceptors in the living human brain 1. Irreversible binding of ligands
  publication-title: J Cereb Blood Flow Metab
– volume: 10
  start-page: 740
  year: 1990
  end-page: 747
  article-title: Graphical analysis of reversible radioligand binding from time-activity measurements applied to [n-11C-methyl]-(-)-cocaine PET studies in human subjects
  publication-title: J Cereb Blood Flow Metab
– volume: 55
  start-page: 33
  year: 1994
  end-page: 36
  article-title: Neuroanatomical targets of neuroleptic drugs as revealed by Fos immunochemistry
  publication-title: J Clin Psychiatry
– volume: 9
  start-page: 696
  year: 1989
  end-page: 708
  article-title: Kinetic analysis of central [ C]raclopri de binding to D -dopamine receptors studied by PET – a comparison to the equilibrium analysis
  publication-title: J Cereb Blood Flow Metab
– volume: 36
  start-page: 1275
  year: 1995a
  end-page: 1281
  article-title: Carbon-11-FLB 457: a radioligand for extrastriatal D2 dopamine receptors
  publication-title: J Nucl Med
– volume: 91
  start-page: 11271
  year: 1994
  end-page: 11275
  article-title: Localization of dopamine D receptors to mesolimbic and D receptors to mesostriatal regions of human forebrain
  publication-title: Proc Natl Acad Sci USA
– volume: 55
  start-page: 79
  year: 1991
  end-page: 96
  article-title: Psychosis and the temporal lobe
  publication-title: Adv Neurol
– volume: 15
  start-page: 568A
  year: 1992
  end-page: 569A
  article-title: Mesoprefrontal cortical dopaminergic activity and prefrontal hypofunction in schizophrenia
  publication-title: Clin Neuropharmacol
– volume: 19
  start-page: 14
  year: 1995
  end-page: 17
  article-title: Haloperidol blocks the uptake of [18F]N-methylspiroperidol by extrastriatal dopamine receptors in schizophrenic patients
  publication-title: Synapse
– volume: 15
  start-page: 643
  year: 1995
  article-title: Comparison of currently applied methods for PET quantification of specific [ C]raclopride binding
  publication-title: J Cereb Blood Flow Metab
– volume: 82
  start-page: 3863
  year: 1985
  end-page: 3867
  article-title: Substituted benzamides as ligands for visualization of dopamine receptor binding in the human brain by positron emission tomography
  publication-title: Proc Natl Acad Sci USA
– volume: 4
  start-page: 153
  year: 1996
  end-page: 158
  article-title: Simplified Reference Tissue Model for PET Receptor Studies
  publication-title: Neuroimage
– volume: 564
  start-page: 203
  year: 1991
  end-page: 219
  article-title: Localization of dopamine-D receptor mRNA in the rat brain using hybridization histochemistry: comparison with dopamine-D receptor mRNA
  publication-title: Brain Res
– volume: 128
  start-page: 240
  year: 1996b
  end-page: 247
  article-title: Autoradiographic localization of D -dopamine receptors in the human brain using the selective D -dopamine receptor agonist [+)-[3H)PD 128097
  publication-title: Psychopharmacol
– volume: 23
  start-page: 813
  year: 1996
  end-page: 819
  article-title: Preparation of [ Br]FLB 457, [ Br]FLB 463 and for examination of striatal and extrastriatal dopamine D2 receptors with PET
  publication-title: Nucl Med Biol
– volume: 16
  start-page: 42
  year: 1996
  end-page: 52
  article-title: Comparison of methods for analysis of clinical [ C]raclopride studies
  publication-title: J Cereb Blood Flow Metab
– volume: 86
  start-page: 6412
  year: 1989
  end-page: 6416
  article-title: Dopamine D receptors in the cerebral cortex: Distribution and pharmacological characterization with [ H]raclopride
  publication-title: Proc Nat! Acad Sci USA
– volume: 779
  start-page: 58
  year: 1998
  end-page: 74
  article-title: D3 dopamine receptor mRNA is widely expressed in the human brain
  publication-title: Brain Res
– volume: 385
  start-page: 634
  year: 1997
  end-page: 636
  article-title: Decreased prefrontal dopamine D1-receptors in schizophrenia revealed by PET
  publication-title: Nature
– volume: 221
  start-page: 1264
  year: 1983
  end-page: 1266
  article-title: Imaging dopamine receptors in the human brain by positron tomography
  publication-title: Science
– volume: 11
  start-page: 245
  year: 1994
  end-page: 256
  article-title: Distribution of D - and D - dopamine receptors, and dopamine and its metabolites in the human brain
  publication-title: Neurpsychopharmacol
– volume: 386
  start-page: 830
  year: 1997
  end-page: 833
  article-title: Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects
  publication-title: Nature
– volume: 35
  start-page: 161
  year: 1976
  end-page: 168
  article-title: Antagonism of the hyperactivity induced by dopamine applied intracerebrally to nucleus accumbens septi by typical neuroleptics and by clozapine, sulpiride and thioridazine
  publication-title: Eur J Pharmacol
– volume: 15
  start-page: 217
  year: 1984
  end-page: 227
  article-title: A quantitative model for the assessment of drug binding sites with positron emission tomography
  publication-title: Ann Neurol
– volume: 20
  start-page: 200
  year: 1995
  end-page: 208
  article-title: Variability in D -dopamine receptor density and affinity: a PET-study with [ C]raclopride in man
  publication-title: Synapse
– volume: 23
  start-page: 115
  year: 1996a
  end-page: 123
  article-title: Autoradiographic localization of extrastriatal D -dopamine receptors in the human brain using [ I]epidepride
  publication-title: Synapse
– volume: 19
  start-page: 716
  year: 1974
  end-page: 723
  article-title: A new look at the statistical model identification
  publication-title: IEEE Trans Automat Contr
– volume: 133
  start-page: 396
  year: 1997b
  end-page: 404
  article-title: A pet study of [C-11)FLB 457 binding to extrastriatal D2-dopamine receptors in healthy subjects and antipsychotic drug-treated patients
  publication-title: Psychopharmacology
– volume: 18
  start-page: 187
  year: 1993
  end-page: 192
  article-title: Dopamine-D3 receptor messenger RNA and binding sites in human brain
  publication-title: Mol Brain Res
– volume: 385
  start-page: 590
  year: 1997a
  article-title: D -dopamine receptors and personality traits
  publication-title: Nature
– volume: 20
  start-page: 60
  year: 1999
  end-page: 80
  article-title: Distribution of dopamine D3 receptor expressing neurons in the human forebrain: comparison with D2 receptor expressing neurons
  publication-title: Neuropsychopharmacol
– ident: bibr18-00004647-199910000-00013
  doi: 10.1007/s002130050131
– volume: 15
  start-page: 643
  year: 1995
  ident: bibr35-00004647-199910000-00013
  publication-title: J Cereb Blood Flow Metab
– ident: bibr2-00004647-199910000-00013
  doi: 10.1111/j.2042-7158.1973.tb10025.x
– ident: bibr17-00004647-199910000-00013
  doi: 10.1002/(SICI)1098-2396(199606)23:2<115::AID-SYN7>3.0.CO;2-C
– ident: bibr27-00004647-199910000-00013
  doi: 10.1097/00004647-199601000-00005
– volume-title: PET Pharmacokinetic Course.
  year: 1997
  ident: bibr29-00004647-199910000-00013
– volume: 261
  start-page: 1282
  year: 1992
  ident: bibr23-00004647-199910000-00013
  publication-title: J Pharmacol Exp Therapeutics
– ident: bibr45-00004647-199910000-00013
  doi: 10.1097/00002826-199201001-00296
– ident: bibr49-00004647-199910000-00013
  doi: 10.1002/syn.890190103
– ident: bibr13-00004647-199910000-00013
  doi: 10.1002/syn.890200303
– ident: bibr22-00004647-199910000-00013
  doi: 10.1007/978-94-011-0429-6_5
– ident: bibr33-00004647-199910000-00013
  doi: 10.1002/ana.410150302
– ident: bibr34-00004647-199910000-00013
  doi: 10.1073/pnas.91.23.11271
– ident: bibr37-00004647-199910000-00013
  doi: 10.1002/ana.410060502
– ident: bibr31-00004647-199910000-00013
  doi: 10.1016/0969-8051(96)00078-9
– ident: bibr24-00004647-199910000-00013
  doi: 10.1016/0006-8993(93)90878-Q
– ident: bibr48-00004647-199910000-00013
  doi: 10.1038/jcbfm.1986.27
– ident: bibr44-00004647-199910000-00013
  doi: 10.1126/science.6604315
– ident: bibr19-00004647-199910000-00013
  doi: 10.1007/BF02244067
– volume: 55
  start-page: 33
  year: 1994
  ident: bibr15-00004647-199910000-00013
  publication-title: J Clin Psychiatry
– ident: bibr8-00004647-199910000-00013
  doi: 10.1016/0306-4522(95)00357-6
– ident: bibr38-00004647-199910000-00013
– ident: bibr11-00004647-199910000-00013
  doi: 10.1038/jcbfm.1989.98
– ident: bibr1-00004647-199910000-00013
  doi: 10.1109/TAC.1974.1100705
– ident: bibr30-00004647-199910000-00013
  doi: 10.1073/pnas.86.16.6412
– ident: bibr28-00004647-199910000-00013
  doi: 10.1016/0169-328X(93)90188-U
– ident: bibr3-00004647-199910000-00013
  doi: 10.1097/00004728-198102000-00027
– ident: bibr42-00004647-199910000-00013
  doi: 10.1016/S0006-8993(97)01078-0
– ident: bibr14-00004647-199910000-00013
  doi: 10.1007/s002130050420
– ident: bibr32-00004647-199910000-00013
  doi: 10.1038/jcbfm.1990.127
– ident: bibr5-00004647-199910000-00013
  doi: 10.1016/S0166-2236(84)80013-2
– ident: bibr39-00004647-199910000-00013
  doi: 10.1214/aos/1176344136
– volume: 40
  start-page: 179
  year: 1997
  ident: bibr43-00004647-199910000-00013
  publication-title: J Labelled Cpd Radiopharm
– ident: bibr16-00004647-199910000-00013
  doi: 10.1016/S0893-133X(98)00066-9
– ident: bibr10-00004647-199910000-00013
  doi: 10.1073/pnas.82.11.3863
– volume: 36
  start-page: 1275
  year: 1995
  ident: bibr21-00004647-199910000-00013
  publication-title: J Nucl Med
– ident: bibr9-00004647-199910000-00013
  doi: 10.1109/23.12815
– volume: 55
  start-page: 79
  year: 1991
  ident: bibr41-00004647-199910000-00013
  publication-title: Adv Neurol
– ident: bibr26-00004647-199910000-00013
  doi: 10.1006/nimg.1996.0066
– ident: bibr46-00004647-199910000-00013
  doi: 10.1097/00004728-199401000-00023
– volume: 24
  start-page: 483
  year: 1997
  ident: bibr25-00004647-199910000-00013
  publication-title: Eur J Nucl Med
– ident: bibr12-00004647-199910000-00013
  doi: 10.1038/385590a0
– ident: bibr7-00004647-199910000-00013
  doi: 10.1176/ajp.148.11.1474
– ident: bibr36-00004647-199910000-00013
  doi: 10.1038/385634a0
– ident: bibr20-00004647-199910000-00013
  doi: 10.1038/sj.npp.1380111
– ident: bibr40-00004647-199910000-00013
  doi: 10.1038/347146a0
– ident: bibr4-00004647-199910000-00013
  doi: 10.1016/0006-8993(91)91456-B
– ident: bibr6-00004647-199910000-00013
  doi: 10.1016/0014-2999(76)90311-3
– ident: bibr47-00004647-199910000-00013
  doi: 10.1038/386830a0
SSID ssj0008355
Score 2.0076058
Snippet Positron emission tomography (PET) has hitherto been used to examine D2 dopamine receptor binding in the striatum, a region with a high density of receptors....
SourceID swepub
pubmed
pascalfrancis
crossref
sage
SourceType Open Access Repository
Index Database
Enrichment Source
Publisher
StartPage 1164
SubjectTerms Adult
Binding Sites
Biological and medical sciences
Carbon Radioisotopes
Cerebellum - chemistry
Cerebellum - metabolism
Dopamine Antagonists
Humans
Investigative techniques, diagnostic techniques (general aspects)
Kinetics
Male
Medical sciences
Nervous system
Putamen - chemistry
Putamen - metabolism
Pyrrolidines
Radiodiagnosis. Nmr imagery. Nmr spectrometry
Receptors, Dopamine D2 - metabolism
Reference Standards
Salicylamides
Temporal Lobe - chemistry
Temporal Lobe - metabolism
Thalamus - chemistry
Thalamus - metabolism
Tomography, Emission-Computed - methods
Tomography, Emission-Computed - standards
Title Quantification of [11C]FLB 457 Binding to Extrastriatal Dopamine Receptors in the Human Brain
URI https://journals.sagepub.com/doi/full/10.1097/00004647-199910000-00013
https://www.ncbi.nlm.nih.gov/pubmed/10532641
http://kipublications.ki.se/Default.aspx?queryparsed=id:1927724
Volume 19
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwGLXKeAAJIdi4DBjyA9tLlSlO4rh-XLt1FUJIiCJVQiiyE0dMpGnVpuLy4_htfL7kUhii7CWKEsVN-p34O46Pz4fQK8oDJSFNwCvuCy8ayMDjPMo8PpBAJ_wQMqZx-3wbTz5Er2d01uv97KiWNpU8TX9cu67kJlGFYxBXvUr2PyLbNAoHYB_iC1uIMGx3ivG7jbBan4b3HdNhn5D-6Jiej98M-xFl_eGVXbgCJPPiW7USplCHXgJ5DuPluSaZQB3V0lTdcaJH-2V_qKtH_IW8pmqlZ5wLK3zv58XCKovnqgJUFbUvofl6u3aLuiaiXLcdXqFnvVp7g1Yk_P6r-Fw6LUrhXQLBFs25MeDZVoYWq84HC2NyUEvf6n4tYMSDHDmzKcj1u5R7zLfLLpuOmXcB6He6WUKs9blL2YTYcih_pANrM2zGQXHEtKiGm_kMz1DfNgXW0_6_ZcZGr9iZqTctJU1LZvI-vIVuB4wZmcDlrJUYAbs1Etr6gZ2SrDYNve6etujRvaVYw5ua2xIrHY7kHCG2zG0NIZo-QPcdGPCZheVD1FPlPjo4K0W1mH_HJ9hoi82kzT66M6rrCh6gZBu1eJHjj5gQPPoEiMWAWOwQi6sF3kIsrhGLG8TiqxIDYrFBLDaIfYSm44vpaOK5Mh9eGlFeeVSoHIYlkZQ8i5jQBoWB0MaWXLJMMSLyVKhIxBzYaqakn4WZkDIb5CnQUz8NH6O9clGqpwhnYawoFalMpYoCP-U0UCHPgjTQ4xJBDhGr_9wkdRb4uhJLkfwrwIeINFcurQ3MDtccbcWvvZDHgc_h_BMbz06LFEZTEdznqQ5w4rqa9Q4_dWKh0DSlXePdoS-wp5LYDwcxe3aD53iO7rav8Qu0V6026giYeCVfGrj_AkRiyzs
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Quantification+of+%5B+11+C%5DFLB+457+Binding+to+Extrastriatal+Dopamine+Receptors+in+the+Human+Brain&rft.jtitle=Journal+of+cerebral+blood+flow+and+metabolism&rft.au=Olsson%2C+Hans&rft.au=Halldin%2C+Christer&rft.au=Swahn%2C+Carl-Gunnar&rft.au=Farde%2C+Lars&rft.date=1999-10-01&rft.issn=0271-678X&rft.eissn=1559-7016&rft.volume=19&rft.issue=10&rft.spage=1164&rft.epage=1173&rft_id=info:doi/10.1097%2F00004647-199910000-00013&rft.externalDBID=n%2Fa&rft.externalDocID=10_1097_00004647_199910000_00013
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0271-678X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0271-678X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0271-678X&client=summon